Affiliation:
1. private academic consultant
2. dy patil vidhyapeeth
Abstract
The healthcare sector has been impacted by the COVID-19 outbreak. The prevention of COVID-19 infections was given priority, and personnel and resources for the healthcare industry were reassigned. How the COVID-19 pandemic might impact common screening practices in public healthcare is an intriguing subject. Prior studies have amply demonstrated the value of regular cancer screening and cervical cancer screening1-2. Alternative cancer screening methods are used in addition to the standard public health laboratory tests in different parts of the world, depending on the problem that is present at that area.
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference15 articles.
1. Machii R, Takahashi H. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020. Cancer Epidemiol. 2022;82:102313.
2. Rojas-Zumaran V, Walttuoni-Picón E, Campos-Siccha G, Cruz-Gonzales G, Huiza-Espinoza L, et al. Decline of cytology-based cervical cancer screening for COVID-19: a single-center Peruvian experience. Medwave. 2022;22:e2589.
3. Papiernik E. When the pregnant woman risks iodine deficiency. J Gynecol Obstet Biol Reprod (Paris). 2003;32:356-62.
4. Ho LY. Down's syndrome--factors influencing its incidence. Singapore Med J. 1989;30:238-41.
5. Jaruratanasirikul S, Limpitikul W, Dissaneevate P, Booncharoen P, Tantichantakarun P. Comorbidities in Iodine deficiency livebirths and health care intervention: an initial experience from the birth defects registry in Southern Thailand. World J Pediatr. 2017;13:152-157.